Huawei’s Patent Licensing Success and the Rise of RoboSense in Autonomous Driving
Recent trends have shown a significant decline in ANDA (Abbreviated New Drug Application) cases, reflecting broader changes in the pharmaceutical industry that do not directly impact technology companies like Huawei. However, for Huawei, this period has seen a surge in revenue from patent licensing activities, which are now contributing significantly to the company's financial health and innovation capabilities.
One of the standout stories from the Huawei camp is the rise of RoboSense, a subsidiary known for its LiDAR sensors used in autonomous driving solutions. In an exclusive interview with IAM Patent, RoboSense provided insights into their latest advancements, which are set to revolutionize the auto industry's approach to safety and efficiency. The company’s commitment to innovation al...









